Substance Use

In this episode of Beyond Substance podcast, Jason Rush shares his journey through addiction and hepatitis C, while Dr. Janet Arno provides expert insight on treatment and public health solutions.

This journal explores the evolution of HIV diagnostic testing, from early antibody-based methods to advanced molecular and rapid point-of-care technologies. It highlights the impact of these innovations on early detection, treatment initiation, and global efforts to control HIV transmission.

This is an interactive map from HepVu that demonstrates opioid prescription in the United States in 2021.

This is an interactive map from HepVu that demonstrates overdose mortality in the United States in 2021.

This publication discusses how people who engage in drug use or high-risk behaviors associated with drug use put themselves at risk for contracting or transmitting viral infections such as HIV/AIDS or hepatitis.

This resource provides an overview of stimulants and aims to educate individuals and organizations that provide services to people who use methamphetamine and other stimulants. This resource offers education on the reasons people take stimulants, including the potential positive aspects to use and potential risks of use; how to minimize harm, reduce stigma around stimulants, and support peoples’ positive experiences. It discusses the intersection of stimulant use and sexual safety; tips

This 90-minute webinar was held for clinicians and others who provide services to TB patients or persons at risk for TB with significant alcohol and/or tobacco use.

The Policy Guidelines outline the detailed evidence and explanation of the recommendations and describe the methods, the people involved and the summary of conflicts of interest. The aim of this guidance is to provide a strategic
approach to reducing TB- and HIV-related morbidity and mortality among drug users and their communities in a way that promotes holistic and person-centred services.